Healthcare Industry News:  degenerative disc disease 

Devices Orthopaedic Neurosurgery FDA

 News Release - February 14, 2007

Scient'x USA Announces 510(K) Clearance for Isobar LP(R) Low Profile Pedicle Screw System

MAITLAND, Fla., Feb. 14 (HSMN NewsFeed) -- Scient'x USA, manufacturer of innovative spinal implant technologies, today announced the receipt of 510K clearance to market their new Isobar LP® Low Profile Pedicle Screw System. The Isobar LP® System offers a top loading tulip head design with an inner locking set screw to offer more space in the construct. The screws feature a self-tapping design and are available in a wide variety of diameters and lengths for thoracic, lumbar and sacral areas,

This pedicle screw system works in conjunction with the other components in the Isobar TTL system including the EASYS Crosslink and Dynamic TTL-Rod which provides controlled micro motion in compression, distraction, flexion, extension, and rotation.

Timothy Seese, COO of Scient'x USA, indicated that the Isobar LP® Low Profile Pedicle Screw System is a key addition to the Isobar TTL System. "The Isobar LP Pedicle Screw System offers surgeons the option to use a smaller, lower profile screw which allows more space in the overall construct when used with the Dynamic TTL-Rod," said Mr. Seese.

Scient'x USA Inc. is a diversified spinal company that designs, manufactures, markets and distributes a comprehensive and innovative range of quality spinal devices. Based in Orlando, Florida, Scient'x USA offers a range of products to treat conditions such as lumbar instability, trauma, and degenerative disc disease. Scient'x USA has become known for producing and marketing the "Isobar TTL Dynamic Spine Stabilization System" and continues to develop new products in conjunction with surgeon physicians for the Orthopaedic and Neurological community. For more information visit

Except for the historical information contained herein, the matters discussed are forward looking statements made pursuant to the safe harbor provisions of the private securities litigation form act of 1995. These statements involved risks and uncertainties, such as regulatory approvals, manufacturing uncertainties, the impacts of competitive products and pricing, and other risks and uncertainties set forth.

Source: Scient'x

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.